Search results

Search for "meso-tetrakis(p-hydroxyphenyl)porphyrin" in Full Text gives 1 result(s) in Beilstein Journal of Nanotechnology.

A redox-responsive viologen–cavitand nanocarrier for dual-function photodynamic therapy

  • Andrey A. Maslennikov,
  • Alexey Yu. Usanyov,
  • Amir A. Shamsutdinov,
  • Anna P. Lyubina,
  • Andrey A. Parfenov,
  • Alexandra D. Voloshina,
  • Irek R. Nizameev,
  • Marsil K. Kadirov,
  • Rezeda R. Fazleeva,
  • Vitaly V. Yanilkin,
  • Kseniya A. Zhdanova,
  • Natal’ya A. Bragina,
  • Albina Y. Ziganshina and
  • Igor S. Antipin

Beilstein J. Nanotechnol. 2026, 17, 1142–1158, doi:10.3762/bjnano.17.78

Graphical Abstract
  • this, we developed a redox-responsive polymeric nanocarrier through free-radical polymerization of a pre-assembled micellar ensemble. This ensemble formed spontaneously in aqueous solution by encapsulating the hydrophobic photosensitizer meso-tetrakis(p-hydroxyphenyl)porphyrin within a core composed of
  • cell death mechanisms were confirmed by flow cytometry and fluorescence microscopy, establishing the developed redox-responsive system as an effective candidate for targeted photodynamic therapy. Keywords: glutathione-triggered release; meso-tetrakis(p-hydroxyphenyl)porphyrin; photodynamic therapy
  • -Tetrakis(p-hydroxyphenyl)porphyrin (THPP) has been extensively studied as an isomer of temoporfin, marketed under the trade name Foscan®. However, unlike its meta-isomer, THPP was halted at the preclinical testing stage in favor of Foscan® development [19][20]. Due to the presence of p-hydroxyphenyl groups
PDF
Album
Supp Info
Full Research Paper
Published 19 Aug 2026
Other Beilstein-Institut Open Science Activities